one) and Drug Interactions (7)]. The risk of hypoglycemia may be decreased by a discount within the dose of sulfonylurea (or other concomitantly administered insulin secretagogue) or insulin. Advise individuals making use of these concomitant medicines of the potential risk of hypoglycemia and educate them to the signs and signs and symptoms of hyp